Leuprolide acetate and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Leuprolide acetate (leuprolide acetate), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Bicalutamide, and have Prostate cancer stage iv.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Leuprolide acetate. It is created by eHealthMe based on reports of 6,881 people who have side effects when taking Leuprolide acetate from the FDA, and is updated regularly.

What is Leuprolide acetate?

Leuprolide acetate has active ingredients of leuprolide acetate. eHealthMe is studying from 6,910 Leuprolide acetate users. Check the latest studies of Leuprolide acetate.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,884 drugs and 2,619 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,881 people reported to have side effects when taking Leuprolide acetate.
Among them, 34 people (0.49%) have Intestinal obstruction.

Could Leuprolide acetate cause Intestinal obstruction?

Among these 34 people:

How long have people been on Leuprolide acetate when they have Intestinal obstruction? *

What is the gender of people who have Intestinal obstruction when taking Leuprolide acetate? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Intestinal obstruction when taking Leuprolide acetate? *

What are other drugs people take besides Leuprolide acetate? *

What are other side effects people have besides Intestinal obstruction? *

Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 11.76%
Gastric Cancer (stomach cancer): 4 people, 11.76%
General Physical Health Deterioration (weak health status): 3 people, 8.82%
Genital Haemorrhage (bleeding from genital): 3 people, 8.82%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 3 people, 8.82%
Purulence (containing pus): 3 people, 8.82%
Nausea (feeling of having an urge to vomit): 3 people, 8.82%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 8.82%
Intestinal Stenosis (partial obstruction that causes the centre opening of the intestine to become narrower): 3 people, 8.82%
Ileal Perforation: 3 people, 8.82%

What are the existing conditions these people have? *

Prostate Cancer Stage Iv: 11 people, 32.35%
Prostate Cancer Stage Ii: 7 people, 20.59%
Pain: 6 people, 17.65%
Prostate Cancer: 6 people, 17.65%
Indigestion: 3 people, 8.82%
Colon Cancer: 3 people, 8.82%
Constipation: 3 people, 8.82%
Nausea (feeling of having an urge to vomit): 3 people, 8.82%
Urination - Painful: 2 people, 5.88%
High Blood Pressure: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Leuprolide acetate and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Leuprolide acetate:

Leuprolide acetate (6,910 reports)

Browse all side effects of Leuprolide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,884 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,619 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Leuprolide acetate) and Leuprolide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.